Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 8.99
- Piotroski Score 3.00
- Grade Outperform
- Symbol (NGNE)
- Company Neurogene Inc.
- Price $19.78
- Changes Percentage (-42.71%)
- Change -$14.74
- Day Low $18.94
- Day High $23.79
- Year High $74.49
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/18/2024
- Fiscal Year End N/A
- Average Stock Price Target $57.00
- High Stock Price Target $60.00
- Low Stock Price Target $49.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) $0.00
- Trailing P/E Ratio N/A
- Forward P/E Ratio N/A
- P/E Growth N/A
- Net Income $-36,317,000
Income Statement
Quarterly
Annual
Latest News of NGNE
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Mike Tyson gets too real with 14-year-old interviewer, talks of death and nothingness
Mike Tyson surprised a teenage journalist with his bleak views on legacy and life during a media interview in 2020. He dismissed the concept of legacy as meaningless and emphasized the transient natur...
By NBC News | 3 days ago -
'The law is clear': US states signal willingness to prosecute election crimes
Several battleground states are cracking down on officials who interfere with elections or refuse to certify results, warning of criminal charges or penalties. This increased oversight aims to prevent...
By The Guardian | 1 month ago -
In Vogue: The 90s review - Anna Wintour and pals offer up hour after hour of fabulous nothingness
"In Vogue: The 90s" showcases iconic figures like Naomi Campbell and Kate Moss, with insights from Anna Wintour, Carlyne Cerf de Dudzeele, and Hamish Bowles....
By The Guardian | 2 months ago
